<DOC>
	<DOCNO>NCT00488176</DOCNO>
	<brief_summary>The aim study compare effect montelukast cetirizine allergic inflammation measure exhaled nitric oxide concentration child seasonal allergic rhinitis .</brief_summary>
	<brief_title>Comparison Effect Montelukast Cetirizine Allergic Inflammation Children With Allergic Rhinitis</brief_title>
	<detailed_description>During pollen season child seasonal allergic rhinitis without concomitant asthma risk allergic inflammation lower respiratory tract . About 60 % child seasonal allergic rhinitis present bronchial hyperresponsiveness sign symptom asthma . The aim study compare effect montelukast cetirizine allergic inflammation measure exhaled nitric oxide concentration child seasonal allergic rhinitis .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>clinical symptom seasonal allergic rhinitis last two season , moderate severe accord ARIA guideline diagnosis bronchial asthma allergy perennial allergen specific immunotherapy chronic disease tobacco smoke acute respiratory tract infection exclude drug : inhale systemic glucocorticosteroids</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>seasonal allergic rhinitis</keyword>
	<keyword>child</keyword>
	<keyword>montelukast</keyword>
	<keyword>cetirizine</keyword>
</DOC>